BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15040599)

  • 61. Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy.
    Luca G; Mancuso F; Calvitti M; Arato I; Falabella G; Bufalari A; De Monte V; Tresoldi E; Nastruzzi C; Basta G; Fallarino F; Lilli C; Bellucci C; Baroni T; Aglietti MC; Giovagnoli S; Cameron DF; Bodo M; Calafiore R
    Xenotransplantation; 2015; 22(4):273-83. PubMed ID: 26134468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 4-Methylcatechol-induced cell damage in TM4 Sertoli cells.
    Li C; Li W; Chen S; Kang Z; Sun L; Li H; Chen L; Rao J; Zhao Y; Yu J; Zhou X
    Cell Biol Int; 2015 Jun; 39(6):770-4. PubMed ID: 25639863
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice.
    O'Shaughnessy PJ; Morris ID; Huhtaniemi I; Baker PJ; Abel MH
    Mol Cell Endocrinol; 2009 Jul; 306(1-2):2-8. PubMed ID: 19059463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Follicle-stimulating hormone increases testicular Anti-Mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5'-monophosphate-mediated activation of the AMH Gene.
    Lukas-Croisier C; Lasala C; Nicaud J; Bedecarrás P; Kumar TR; Dutertre M; Matzuk MM; Picard JY; Josso N; Rey R
    Mol Endocrinol; 2003 Apr; 17(4):550-61. PubMed ID: 12554789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transgenic mice as a model to study the regulation of human transferrin expression in Sertoli cells.
    LĂ©cureuil C; Saleh MC; Fontaine I; Baron B; Zakin MM; Guillou F
    Hum Reprod; 2004 Jun; 19(6):1300-7. PubMed ID: 15105395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunoregulatory Sertoli Cell Allografts Engineered to Express Human Insulin Survive Humoral-Mediated Rejection.
    Washburn RL; Hibler T; Kaur G; Sabu-Kurian A; Landefeld A; Dufour JM
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555540
    [TBL] [Abstract][Full Text] [Related]  

  • 67. C-Peptide as a Therapy for Type 1 Diabetes Mellitus.
    Washburn RL; Mueller K; Kaur G; Moreno T; Moustaid-Moussa N; Ramalingam L; Dufour JM
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33800470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulation of blood-testis barrier by actin binding proteins and protein kinases.
    Li N; Tang EI; Cheng CY
    Reproduction; 2016 Mar; 151(3):R29-41. PubMed ID: 26628556
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The blood-testis barrier and its implications for male contraception.
    Cheng CY; Mruk DD
    Pharmacol Rev; 2012 Jan; 64(1):16-64. PubMed ID: 22039149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gender-dependent survival of allogeneic trophoblast stem cells in liver.
    Epple-Farmer J; Debeb BG; Smithies O; Binas B
    Cell Transplant; 2009; 18(7):769-76. PubMed ID: 19523327
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The testicular-derived Sertoli cell: cellular immunoscience to enable transplantation.
    Emerich DF; Hemendinger R; Halberstadt CR
    Cell Transplant; 2003; 12(4):335-49. PubMed ID: 12911122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel means to selectively identify Sertoli cell transplants.
    Emerich DF; Sanberg PR
    Cell Transplant; 2002; 11(6):495-7. PubMed ID: 12428737
    [No Abstract]   [Full Text] [Related]  

  • 73. Transgenic Sertoli cells as a vehicle for gene therapy.
    Dufour JM; Gores P; Hemendinger R; Emerich DF; Halberstadt CR
    Cell Transplant; 2004; 13(1):1-6. PubMed ID: 15040599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delivery of a therapeutic protein by immune-privileged Sertoli cells.
    Halley K; Dyson EL; Kaur G; Mital P; Uong PM; Dass B; Crowell SN; Dufour JM
    Cell Transplant; 2010; 19(12):1645-57. PubMed ID: 20719072
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suitability of allogeneic sertoli cells for ex vivo gene delivery in the injured spinal cord.
    Trivedi AA; Igarashi T; Compagnone N; Fan X; Hsu JY; Hall DE; John CM; Noble-Haeusslein LJ
    Exp Neurol; 2006 Mar; 198(1):88-100. PubMed ID: 16387298
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression.
    Saporta S; Cameron DF; Borlongan CV; Sanberg PR
    Exp Neurol; 1997 Aug; 146(2):299-304. PubMed ID: 9270038
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.